Barry S. Taylor
Barry S. Taylor
Loxo Oncology, Eli Lilly
Verified email at loxooncology.com - Homepage
Title
Cited by
Cited by
Year
Comprehensive molecular portraits of human breast tumours
CGAR Network
Nature 490 (7418), 61-70, 2012
8390*2012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
R McLendon, A Friedman, D Bigner, EG Van Meir, DJ Brat, ...
Nature 455 (7216), 1061-1068, 2008
59462008
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
55472012
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
53292011
Collision
A Weinstein
Fictions of the Self, 1550-1800, 129-199, 2014
46462014
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
34422010
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
28872012
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
25882013
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network
Nature 499 (7456), 43, 2013
21052013
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703-713, 2017
18652017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
13042018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
12342018
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
BE Johnson, T Mazor, C Hong, M Barnes, K Aihara, CY McLean, ...
Science 343 (6167), 189-193, 2014
11122014
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
9672017
Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled …
H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ...
Journal of Clinical Oncology 36 (7), 633, 2018
8012018
DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
R Rosenthal, N McGranahan, J Herrero, BS Taylor, C Swanton
Genome biology 17 (1), 1-11, 2016
6952016
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ...
Nature genetics 42 (8), 715-721, 2010
6732010
Genome sequencing identifies a basis for everolimus sensitivity
G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ...
Science 338 (6104), 221, 2012
6692012
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ...
The Journal of clinical investigation 126 (3), 1052-1066, 2016
6562016
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma
M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ...
Nature genetics 43 (7), 668-672, 2011
6442011
The system can't perform the operation now. Try again later.
Articles 1–20